MedMen Enterprises Inc. MMNFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

19/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MedMen Enterprises Inc. (MMNFF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 18/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

护城河

51/100

→ Income

✗

成长

30/100

→ Income

✗

收入

10/100

→ Income

估值概览 — MMNFF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.14

每股账面价值$0.00

每股营收$0.12

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-0.93	$24.92K	$-249.92K	-1002.8%
2014	$-0.50	$20.64K	$-122.8K	-594.9%
2015	$-0.56	$26.65K	$-228.14K	-856%
2016	$-0.21	$20.07K	$-124.14K	-618.7%
2017	$-26.33	$2.67M	$-15.42M	-577.1%
2018	$-2.77	$39.78M	$-112.26M	-282.2%
2019	$-2.62	$129.96M	$-277.05M	-213.2%
2020	$-1.76	$157.11M	$-475.75M	-302.8%
2021	$-0.27	$145.07M	$-145.45M	-100.3%
2022	$-0.14	$140.81M	$-165.55M	-117.6%